A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Seagen Inc.
Massachusetts General Hospital
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)